Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Neuroimage Clin ; 25: 102158, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31918064

RESUMEN

BACKGROUND: Deficits in short-term memory (STM) binding are a distinguishing feature of preclinical stages leading to Alzheimer's disease (AD). However, the neuroanatomical correlates of conjunctive STM binding are largely unexplored. Here we examine the possible association between the volumes of hippocampi, parahippocampal gyri, and grey matter within the subcortical structures - all found to have foci that seemingly correlate with basic daily living activities in AD patients - with cognitive tests related to conjunctive STM binding. MATERIALS AND METHODS: Hippocampal, thalamic, parahippocampal and corpus striatum volumes were semi-automatically quantified in brain magnetic resonance images from 25 cognitively normal people and 21 patients with Mild Cognitive Impairment (MCI) at high risk of AD progression, who undertook a battery of cognitive tests and the short-term memory binding test. Associations were assessed using linear regression models and group differences were assessed using the Mann-Whitney U test. RESULTS: Hippocampal and parahippocampal gyrus volumes differed between MCI and control groups. Although the grey matter volume in the globus pallidus (r = -0.71, p < 0.001) and parahippocampal gyry (r = -0.63, p < 0.05) correlated with a STM binding task in the MCI group, only the former remained associated with STM binding deficits in MCI patients, after correcting for age, gender and years of education (ß = -0.56,P = 0.042) although with borderline significance. CONCLUSIONS: Loss of hippocampal volume plays no role in the processing of STM binding. Structures within the basal ganglia, namely the globus pallidus, could be part of the extrahippocampal network supporting binding. Replication of this study in large samples is now needed.


Asunto(s)
Envejecimiento/fisiología , Disfunción Cognitiva/patología , Disfunción Cognitiva/fisiopatología , Cuerpo Estriado/patología , Sustancia Gris/patología , Hipocampo/patología , Memoria a Corto Plazo/fisiología , Giro Parahipocampal/patología , Anciano , Anciano de 80 o más Años , Disfunción Cognitiva/diagnóstico por imagen , Cuerpo Estriado/diagnóstico por imagen , Femenino , Sustancia Gris/diagnóstico por imagen , Hipocampo/diagnóstico por imagen , Humanos , Masculino , Giro Parahipocampal/diagnóstico por imagen , Tálamo/diagnóstico por imagen , Tálamo/patología
2.
Learn Mem ; 16(4): 224-30, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19304892

RESUMEN

To this day, it remains unresolved whether experimental amnesia reflects failed memory storage or the inability to retrieve otherwise intact memory. Methodological as well as conceptual reasons prevented deciding between these two alternatives: The absence of recovery from amnesia is typically taken as supporting storage impairment interpretations; however, this absence of recovery does not positively demonstrate nonexistence of memory, allowing for alternative interpretations of amnesia as impairment of memory retrieval. To address this shortcoming, we present a novel approach to study the nature of amnesia that makes positive, i.e., falsifiable, predictions for the absence of memory. Applying this paradigm, we demonstrate here that infusing anisomycin into the dorsal hippocampus induces amnesia by impairing memory storage, not retrieval.


Asunto(s)
Amnesia/fisiopatología , Hipocampo/fisiopatología , Memoria/fisiología , Amnesia/inducido químicamente , Animales , Anisomicina/administración & dosificación , Anisomicina/toxicidad , Condicionamiento Operante/efectos de los fármacos , Condicionamiento Operante/fisiología , Extinción Psicológica/efectos de los fármacos , Extinción Psicológica/fisiología , Hipocampo/efectos de los fármacos , Inyecciones Intraventriculares , Masculino , Inhibidores de la Síntesis de la Proteína/administración & dosificación , Inhibidores de la Síntesis de la Proteína/toxicidad , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA